Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
abbvie
5
×
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
pfizer
5
×
raleigh-durham blog main
5
×
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
astrazeneca
eli lilly
startups
alzheimer's disease
amgen
biogen
bristol-myers squibb
cancer
cancer immunotherapy
clinical trials
cystic fibrosis
What
bio
5
×
roundup
drug
acquisitions
biggest
biotech
ceo
fda
news
week
albert
alzheimer’s
annual
approved
assessed
attention
august
bourla
build
busy
buy
communities
companies
company
company’s
conference
crispr
daniel
days
debut
decisions
devices
digital
disease
drugs
dyne’s
epidemic
esmo
europe
fatty
Language
unset
unknown
Current search:
pfizer
×
abbvie
×
" raleigh-durham blog main "
×
bio
×
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More